Page 101 - 80_01
P. 101

Class	
  I	
  phosphoinositide	
  3-­-kinases	
  in	
  immunity…	
  

	
  
also	
   PI3K	
   dependent	
   and	
   involves	
   its	
   association	
   with	
   ribosomes,	
   yet	
   the	
   exact	
  
mechanisms	
   are	
   not	
   known	
   (29).	
   At	
   least	
   another	
   well	
   established	
   PDK2	
   activity	
  
for	
   Ser423	
   Akt	
   phosphorylation	
   is	
   mediated	
   by	
   the	
   DNA-­-PK	
   (7,31,32).	
   Doubly	
  
phosphorylated	
   Akt	
   P-­-Thr308Ser423	
   efficiently	
   phosphorylates	
   forkhead	
  
transcription	
  factor/forkhead	
  box	
  (FOXO)	
  transcription	
  factors	
  FOXO1/2	
  to	
  inhibit	
  
their	
  function,	
  with	
  important	
  consequences	
  in	
  lymphocytes	
  (27,33).	
  

4.b.	
  Targets	
  of	
  PI3K:	
  GEFs	
  and	
  Tec.	
  	
  

        The	
   control	
   by	
   PI3Ks	
   of	
   the	
   actin	
   cytoskeleton	
   dynamics	
   mediated	
   by	
   GEF	
  
stimulation	
  of	
  the	
  Rac	
  and	
  Rho	
  GTPases	
  is	
  well	
  established	
  (21).One	
  typical	
  GEF	
  is	
  
Vav,	
  that	
  is	
  activated	
  by	
  Src	
  and	
  Syk	
  family	
  tyrosine	
  kinases	
  but	
  also	
  depends	
  on	
  its	
  
PH	
  and	
  Dbl-­-homology	
  domains	
  for	
  activity	
  (34).	
  

        With	
   one	
   exception,	
   Tec	
   family	
   tyrosine	
   kinases	
   including	
   BTK	
   and	
   Itk	
  
expressed	
   in	
   B	
   and	
   T	
   lymphocytes	
   possess	
   an	
   N	
   terminus	
   PH	
   domain	
   followed	
   by	
  
TH,	
   SH3,	
   SH2,	
   and	
   kinase	
   domains	
   (35,36).	
   The	
   PH	
   domain	
   is	
   determinant	
   to	
  
recruitment	
   of	
   these	
   Tec	
   kinases	
   to	
   membranes,	
   where	
   they	
   can	
   further	
   interact	
  
with	
   specific	
   Tyr-­-phosphorylated	
   substrates	
   and	
   activated	
   by	
   Src	
   family	
   and	
  
autophosphorylation.	
   Tec	
   family	
   tyrosine	
   kinases	
   have	
   phospholipase	
   C	
   enzymes	
  
like	
   PLC?	
   as	
   important	
   substrates	
   within	
   signalosomes	
   generated	
   upon	
   receptor	
  
activation.	
  PLC?	
  then	
  splits	
  PtdIns(4,5)P2	
  into	
  Diacylglicerol	
  and	
  Ins(1,4,5)P3	
  that	
  
in	
   turn	
   are	
   necessary	
   to	
   activate	
   the	
   Ser/Thr	
   kinases	
   PKC?	
   and	
   hence	
   the	
  
Ras/MAPK	
   and	
   the	
   IKK/NF?B	
   pathways,	
   or	
   the	
   Ins(1,4,5)P3-­-Ca2+-­-dependent	
  
activation	
  of	
  NFAT	
  family	
  of	
  transcription	
  factors	
  (Figure	
  3).	
  

4.c.	
  Targets	
  of	
  PI3K:	
  PDK1-­-dependent,	
  Akt-­-independent.	
  	
  

        PDK1	
   can	
   associate	
   to	
   and	
   activate	
   additional	
   substrates	
   that	
   are	
   not	
  
dependent	
   on	
   Akt	
   including	
   the	
   Ser/Thr	
   kinases	
   PKC?	
   (37)	
   and	
   the	
   cAMP-­-
dependent	
   kinase	
   PKA	
   (38),	
   with	
   important	
   functional	
   consequences	
   to	
  
lymphocyte	
  activation.	
  	
  

        Of	
   note,	
   although	
   the	
   different	
   pathways	
   initiated	
   by	
   PI3K	
   activation	
   have	
  
specific	
  targets,	
  they	
  can	
  be	
  also	
  connected	
  to	
  reinforce	
  others.	
  For	
  instance,	
  PKC?-­-
mediated	
   activation	
   of	
   IKK/NF?B	
   is	
   targeted	
   in	
   a	
   PI3-­-dependent	
   manner	
   through	
  
PDK1-­-,	
  mTORC2-­-	
  and	
  Tec-­-dependent	
  mechanisms.	
  

5.	
  CLASS	
  I-­-PI3KINASES:	
  RELEVANCE	
  TO	
  CANCER	
  

        The	
   clues	
   for	
   an	
   association	
   of	
   PI3K	
   and	
   tumor	
   development	
   and	
   growth	
  
come	
   from	
   different	
   sources.	
   On	
   one	
   hand,	
   some	
   oncogenic	
   retroviruses	
   possess	
  
genes	
   derived	
   from	
   those	
   encoding	
   p110a	
   and	
   AKT.	
   On	
   the	
   other,	
   the	
  
PtdIns(3,4,5)P3	
  phosphatase	
  PTEN	
  is	
  a	
  tumor	
  suppressor	
  gene	
  frequently	
  mutated	
  
in	
   human	
   tumors	
   with	
   the	
   consequence	
   of	
   a	
   constitutive	
   activation	
   of	
   the	
   PI3K	
  

                                                                                                                             	
  99	
  

	
  
   96   97   98   99   100   101   102   103   104   105   106